Octarine Bio (private company)

See something wrong or missing? Let us know
Offices:
Copenhagen
Business model:
B2B
Investors:
we tracked 2 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Octarine Bio is a synthetic biology company developing superior cannabinoid and psilocybin derivatives for the pharmaceutical industry.

Companies with similar profile to Octarine Bio:

CompanyCriteria
Spain ViveBiotech
44%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain BiCat
44%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark STipe Therapeutics
44%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
44%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Asarina Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Norway Oivi
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Anaconda Biomed
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Sanifit Therapeutics
44%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Iceland Alvotech
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Leuko
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Flow Neuroscience
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Creat Sens
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland Sooma Medical
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark AFYX Therapeutics
44%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark BioPhero
44%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Norway TAG Sensors
44%
  • Similar verticals: Manufacturing, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Vytrus Biotech
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Amadix
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Bigfinite
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain The Beemine Lab
44%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes